News & Articles

Selected Filters:

Antibodies Clear Filters

Expert Insights

Translatable efficacy & safety testing of mAb, bispecific, & CAR T therapies

12 Dec 2023

Editorial Article

The potential of immunoproteomics in type 2 diabetes as a diagnostic and prognostic tool to combat bacterial infection

28 Nov 2023

Editorial Article

How to unite diagnostic and antimicrobial stewardship for improved patient care

21 Nov 2023

Editorial Article

Enhance antibody and lateral flow assay development through partnership with experts

20 Nov 2023

Industry News

Glox Therapeutics secures £4.3M seed funding to develop precision antimicrobials targeting drug-resistant bacteria

15 Nov 2023

Editorial Article

SelectScience Cancer Research Summit 2023 – Taking place today!

14 Nov 2023

Industry News

SelectScience introduces its new merch

13 Nov 2023

Editorial Article

Post-translational modification research offers new insights into health and disease

23 Oct 2023

Editorial Article

Latest advances in biopharma research enhance targeted therapies

5 Oct 2023

Editorial Article

Maximize success in biotherapeutic antibody development

1 Oct 2023

News & Articles

Articles Filter

Search

Selected Filters:

Translatable efficacy & safety testing of mAb, bispecific, & CAR T therapies

The potential of immunoproteomics in type 2 diabetes as a diagnostic and prognostic tool to combat bacterial infection

How to unite diagnostic and antimicrobial stewardship for improved patient care

Enhance antibody and lateral flow assay development through partnership with experts

Glox Therapeutics secures £4.3M seed funding to develop precision antimicrobials targeting drug-resistant bacteria

SelectScience Cancer Research Summit 2023 – Taking place today!

SelectScience introduces its new merch

Post-translational modification research offers new insights into health and disease

Latest advances in biopharma research enhance targeted therapies

Maximize success in biotherapeutic antibody development

News & Articles

Articles FilterArticles Filter

Search

Selected Filters:

Translatable efficacy & safety testing of mAb, bispecific, & CAR T therapies

The potential of immunoproteomics in type 2 diabetes as a diagnostic and prognostic tool to combat bacterial infection

How to unite diagnostic and antimicrobial stewardship for improved patient care

Enhance antibody and lateral flow assay development through partnership with experts

Glox Therapeutics secures £4.3M seed funding to develop precision antimicrobials targeting drug-resistant bacteria

SelectScience Cancer Research Summit 2023 – Taking place today!

SelectScience introduces its new merch

Post-translational modification research offers new insights into health and disease

Latest advances in biopharma research enhance targeted therapies

Maximize success in biotherapeutic antibody development

Articles Filter